MESO
Mesoblast Limited - American Depositary Shares (MESO)
$10
About Mesoblast Limited - American Depositary Shares (MESO)
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Details
Daily high
$15.01
Daily low
$13.90
Price at open
$15.01
52 Week High
$21.50
52 Week Low
$11.89
Market cap
1.9B
Dividend yield
-
Volume
255,877
Avg. volume
309,722
P/E ratio
-32.08
Mesoblast Limited - American Depositary Shares News
Details
Daily high
$15.01
Daily low
$13.90
Price at open
$15.01
52 Week High
$21.50
52 Week Low
$11.89
Market cap
1.9B
Dividend yield
-
Volume
255,877
Avg. volume
309,722
P/E ratio
-32.08